The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Reilly Joseph H. since 2014.
The trader's CIK number is 1610499.
At the time of the last reporting, Reilly Joseph H. was the SVP & Chief Operating Officer of Minerva Neurosciences, Inc.. (stock ticker symbol NERV).
Also see all insider trading activities at Minerva Neurosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | NERV | 0 | $0 | 3,228 | $8,521 | 8,750 | $0 |
| 2019 | NERV | 0 | $0 | 2,724 | $19,340 | 8,750 | $0 |
| 2018 | NERV | 0 | $0 | 52,728 | $578,350 | 58,750 | $241,500 |
| 2017 | NERV | 0 | $0 | 4,506 | $36,102 | 10,350 | $7,536 |
| 2014 | NERV | 8,333 | $49,998 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-14 | NERV | Option Ex | 8,750 | .00 | 0 |
| 2020-12-16 | NERV | Sale | 3,228 | 2.64 | 8,521 |
| 2019-12-14 | NERV | Option Ex | 8,750 | .00 | 0 |
| 2019-12-17 | NERV | Sale | 2,724 | 7.10 | 19,340 |
| 2018-12-14 | NERV | Option Ex | 8,750 | .00 | 0 |
| 2018-12-17 | NERV | Sale | 2,728 | 7.46 | 20,350 |
| 2018-10-01 | NERV | Option Ex | 25,000 | 4.95 | 123,750 |
| 2018-10-01 | NERV | Sale | 25,000 | 12.32 | 308,000 |
| 2018-08-23 | NERV | Option Ex | 25,000 | 4.71 | 117,750 |
| 2018-08-23 | NERV | Sale | 25,000 | 10.00 | 250,000 |
| 2017-12-14 | NERV | Option Ex | 8,750 | .00 | 0 |
| 2017-12-14 | NERV | Sale | 2,906 | 5.80 | 16,854 |
| 2017-01-11 | NERV | Option Ex | 1,600 | 4.71 | 7,536 |
| 2017-01-11 | NERV | Sale | 1,600 | 12.03 | 19,248 |
| 2014-07-01 | NERV | Buy | 8,333 | 6.00 | 49,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reilly Joseph H. (SVP & Chief Operating Officer of Minerva Neurosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.